News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
BioCurex Inc. Announces Amendments to Licensing Agreement
March 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RICHMOND, British Columbia, March 20, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to announce that it has reached an agreement in principle to amend its licensing agreement, dated April 2005, with its first Licensee as follows:
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoff Tracker
BioNTech Will Close Singapore Plant, Affecting 85 Employees
April 6, 2026
·
46 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
April 6, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot
April 3, 2026
·
2 min read
·
Nick Paul Taylor
Tariffs
Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow
April 3, 2026
·
2 min read
·
Nick Paul Taylor
